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Aims. Prevalence and covariates of subclinical psychosis have gained increased interest in the context of early identi-
fication and treatment of persons at risk for psychosis.
Methods. We analysed 9829 adults representative of the general population within the canton of Zurich, Switzerland.
Two psychosis syndromes, derived from the SCL-90-R, were applied: ‘schizotypal signs’ and ‘schizophrenia nuclear
symptoms’.
Results. Only a few subjects (13.2%) reported no schizotypal signs. While 33.2% of subjects indicated mild signs, only a
small proportion (3.7%) reported severe signs. A very common outcome was no ‘schizophrenia nuclear symptoms’
(70.6%). Although 13.5% of the participants reported mild symptoms, severe nuclear symptoms were very rare
(0.5%). Because these two syndromes were only moderately correlated (r = 0.43), we were able to establish sufficiently
distinct symptom clusters. Schizotypal signs were more closely connected to distress than was schizophrenia nuclear
symptoms, even though their distribution types were similar. Both syndromes were associated with several covariates,
such as alcohol and tobacco use, being unmarried, low education level, psychopathological distress and low subjective
well-being.
Conclusions. Subclinical psychosis symptoms are quite frequent in the general population but, for the most part, are
not very pronounced. In particular, our data support the notion of a continuous Wald distribution of psychotic symp-
toms in the general population. Our findings have enabled us to confirm the usefulness of these syndromes as pre-
viously assessed in other independent community samples. Both can appropriately be associated with well-known
risk factors of schizophrenia.
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Introduction
Although significant variability exists between inci-
dence and prevalence rates of schizophrenia, the aver-
age annual incidence is about 0.2 per 1000 persons,
with a lifetime prevalence of 0.4–0.7% (Rössler et al.
2005). While schizophrenia can be considered a rela-
tively rare disease, subclinical psychosis symptoms
are much more frequent in the general population
(Scott et al. 2006; Rössler et al. 2007) and in socio-
culturally different countries (Loch et al. 2011). These
symptoms are commonly referred to as psychotic-(like)
experiences, proneness to psychosis, at-risk mental
state, schizotypy or exceptional experiences (Fach
et al. 2013). A recent systematic review of 61 reported
incidence and prevalence studies of population rates
for subclinical psychosis symptoms revealed a median
prevalence rate of 7.2% and a median annual incidence
rate of 2.5%, with significant variation detected in
those rates (Linscott & van Os, 2013).
Subclinical psychosis symptoms, although not
always of clinical relevance (Johns & van Os 2001),
can have predictive power for the onset of clinical psy-
chotic disorders later in life (van Os et al. 2000). As such,
the topic has gained increased interest within the con-
text of early identification and treatment of persons at
risk for psychosis. Because of various early intervention
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programmes, a new category was proposed for intro-
duction in DSM-5 to address this ‘psychosis risk syn-
drome’, which describes a condition ‘with recent onset
of modest psychotic-like symptoms and clinically rel-
evant distress and disability’ (Tsuang et al. 2013).
However, the data showed that only a minority of
persons develops a diagnosable psychotic disorder
(Fusar-Poli et al. 2012). Another newly discussed cat-
egory, the ‘attenuated psychosis syndrome’, did not
necessarily imply a transition of subclinical psychosis
to a full psychotic disorder. It also was discounted
because certainty was lacking about its validity and
reliability. Moreover, it was unclear how this attenuated
psychosis syndrome could be delimited from a schizo-
typal personality disorder (Tsuang et al. 2013).
One explanation for the fuzziness of this concept is
the ‘near Babylonian speech confusion’ within this
field. Schultze-Lutter et al. (2011) have argued that
this at-risk nomenclature lacks clarity with the emer-
gence of ever-new terms and concepts. Indeed, no
comprehensive picture currently describes what actu-
ally constitutes subclinical psychosis. Therefore, to
reduce its heterogeneity of assessed symptoms,
researchers must define more general psychopatholo-
gical categories.
We have previously employed several independent
community samples and populations – in particular,
data from the ‘Zurich Study’ (Angst et al. 2005) – to
evaluate subclinical psychosis with higher-order syn-
dromes, as derived from the SCL-90-R. In that unique
small-community sample, which we followed longi-
tudinally over 30 years, we identified subclinical
psychosis syndromes with relevant distress and func-
tional disability (Rössler et al. 2007). Although none
of those participating individuals developed a psycho-
tic disorder, persons with persisting subclinical psycho-
sis syndromes were found to be at risk for developing
other mental disorders (Rössler et al. 2011a).
To validate some of these results, we have now con-
ducted a cross-sectional study in which we analysed
those two previously established psychosis syn-
dromes. Here, a new, much larger sample of adults,
20–41 years old, was followed. They were considered
representative of the general population of the canton
of Zurich, Switzerland. Our objectives were to (i)
determine the distribution of these syndromes, (ii) esti-
mate their prevalence and comorbidity, and (iii) inves-
tigate their associations using several covariates.
Methods
Study design and sampling
This study was conducted as part of the ‘Zurich
Programme for Sustainable Development of Mental
Health Services’ (ZInEP, i.e. ‘Zürcher Impulsprogramm
zur nachhaltigen Entwicklung der Psychiatrie’). This
broadly based public mental health research programme
is located in the canton of Zurich. The Epidemiology
Survey, one of six ZInEP subprojects, comprises four
parts: (1) telephone screening; (2) comprehensive, semi-
structured face-to-face interviews with a stratified sub-
sample; (3) socio-physiological laboratory examination;
and (4) a longitudinal survey. Its design was adapted
from the longitudinal Zurich cohort-study (Angst et al.
2005). For the present analysis, we used data from the
first step of the survey – the telephone screening – col-
lected between August 2010 and May 2012.
The 9829 Swiss male and female participants were
aged 20–41 years at the onset of the survey and were
representative of the general population of the Zurich
canton. All were screened through a computer-assisted
telephone interview (CATI) that utilised the Symptom
Checklist-27 (SCL-27) (Hardt et al. 2004) plus items
from the psychoticism and paranoid ideation subscales
of the SCL-90-R (Derogatis, 1977). Additional items
included assessments of socio-demography and sub-
stance use.
Participants were randomly selected through the
registration offices of all municipalities within the can-
ton, and residents without Swiss nationality were
excluded. In accordance with detailed instructions
from the research team, a leading marketing and field
research institute (GfK ‘Growth for Knowledge’), con-
ducted each CATI. In all, 14 professional telephone
interviewers were employed, with seven of them cover-
ing 76% of all 9829 interviews. The overall response rate
was 53.6%. Reasons for non-response were no tele-
phone connection, only telephone answering machine,
incorrect telephone number, communication imposs-
ible, unavailability during the study period, or refusal
by a the targeted person him/herself or a third person.
In cases where potential participants were available
by telephone, the response rate was 73.9%.
The Cantonal Ethics Committee (KEK) of Zurich
approved the ZInEP Epidemiology Survey to fulfil all
legal and data privacy protection requirements. The
survey was performed in strict accordance with the
Declaration of Helsinki of the World Medical
Association. All participants gave their written
informed consent.
Instruments and measures
The SCL-27 (Hardt et al. 2004) is a German short-form
of the well-known SCL-90-R (Derogatis, 1977), which
is used to report a wide variety of psychiatric symp-
toms over the most recent 4-week period. Subjects
respond according to a five-point Likert scale that
ranges from (1) ‘not at all’ to (5) ‘extremely’. Six
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subscales of symptoms are included: depressive,
dysthymic, vegetative, agoraphobic, socio-phobic and
mistrust. A total distress score similar to the GSI in
the SCL-90-R is also available. Cronbach’s α for the
subscales are all greater 0.70 and Cronbach’s α for
the GSI is 0.93. The correlation between the GSI of
the SCL-27 and the GSI of the SCL-90-R is r = 0.95
(Hardt et al. 2004). Here, we added items from the psy-
choticism and paranoid ideation subscales of the orig-
inal SCL-90-R to those of the mistrust subscale. This
provided two re-arranged subscales of subclinical psy-
chosis that we had previously established in the Zurich
Study (Rössler et al. 2007). The first new subscale was
used to address social and interpersonal deficiencies,
as evidenced by a reduced capacity for close relation-
ships as well as ideas of reference, odd beliefs, and
suspicion/paranoid ideation. As such, this factor was
reminiscent of symptoms corresponding to a schizoty-
pal personality disorder. Thus, we named this subscale
‘schizotypal signs’. The second new subscale – ‘schizo-
phrenia nuclear symptoms’ – included items of
thought insertion, thought-broadcasting, thought con-
trol and hearing voices (Table 1). Those symptoms rep-
resent attenuated forms of the nuclear symptoms of
schizophrenia. A detailed description of the develop-
ment of these subscales is provided elsewhere (see
Rössler et al. 2007). They have also been replicated
and applied in other representative samples
(Breetvelt et al. 2010; Rössler et al. 2011b). Categories
of distress for both subscales were defined as follows:
‘no distress’, with a mean value <1.00; ‘low distress’,
1.01–1.49; ‘moderate distress’, 1.50–1.99; ‘high
distress’, 2.00–2.99; and ‘extreme distress’, with a
mean value >2.99
All other variables included in the analysis were
also assessed during the CATI, with most proposing
a single question and standardised response options.
Topics covered alcohol use, smoking, children, civil
state, housing and sex, as well as a self-evaluation of
the individual’s satisfaction with their mental health
and a comparison with that of other persons. In
addition, participants were asked about abusive drink-
ing and level of education. The former was assessed
with the question, ‘Some people may have a drink
too much at a party or special occasion. Does this hap-
pen to you as well from time to time?’. Education level
was defined as ‘low’ when high school or simple occu-
pation was the highest level achieved, ‘moderate’
when college or specialised occupation was the upper-
most, and ‘high’ when university was the highest
degree attained.
Statistical analysis
Associations between the categories of ‘schizotypal
signs’ and ‘schizophrenia nuclear symptoms’ were
analysed with contingency tables and χ2 tests.
Associations with the continuous psychosis subscales
were examined with generalised linear models. Since
both subscales were heavily peaked and right-skewed,
we fitted models with an inverse Gauss distribution
and log-link function. A robust estimator was used
to reduce the effects of outliers and influential obser-
vations. Results were reported either with mean values
Table 1. Items for the new subscales of ‘schizophrenia nuclear symptoms’ and ‘schizotypal signs’ that replace those for the ‘paranoid ideation’
(PN) and ‘psychoticism’ (PS) subscales from the original SCL-90-R
New SCL-90-R items Original SCL-90-R subscalea
Schizophrenia nuclear symptoms subscale
7: Someone else can control your thoughts PS
16: Hearing voices other people do not hear PS
35: Other being aware of your thoughts PS
62: Having thoughts that are not your own PS
Schizotypal signs subscale
8: Others are to blame for your troubles PN
18: Feeling most people cannot be trusted PN
43: Feeling you are watched by others PN
68: Having ideas others do not share PN
76: Others not giving you proper credit PN
77: Feeling lonely even when with people PS
83: Feeling people take advantage of you PN
88: Never feeling close to another person PS
aItems excluded from the original PS subscale are 84: Thoughts about sex that bother you a lot; 85: Idea you should be punished
for sins; 87: Idea something is wrong with your body; and 90: Idea something is wrong with your mind.
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when related to categorical predictors or with standar-
dised regression coefficients (β) when related to con-
tinuous predictors. All analyses were performed with
SPSS version 20 for Macintosh.
Results
The sample comprised 4908 females and 4919 males.
Ranging from 20 to 41 years, the mean age was 28.9
(S.D. = 7.1). Most interviewed subjects were unmarried
(66.9%), followed by married (30.9%), and separated/
divorced/widowed (2.3%). A total of 2795 (28.4%)
reported having children. Finally, education levels
were low for 43.6% of participants, moderate for
38.0% and high for 18.4%.
The distribution of our two psychosis subscales was
inspected in detail (Fig. 1). ‘Schizotypal signs’ ranged
from 1 to 5, with a mean of 1.623 (S.D. = 0.572), median
of 1.5, skewness of 1.385 (S.E. = 0.025), and a kurtosis of
2.257 (S.E. = 0.049). ‘Schizophrenia nuclear symptoms’
also ranged from 1 to 5, but had a clearly lower
mean of 1.159 (S.D. = 0.332), median of 1.0, skewness
of 3.319 (S.E. = 0.025), and a large kurtosis of 15.989
(S.E. = 0.050). The common feature between them was
their clear representation of an inverse Gaussian
distribution (also known as a Wald distribution). The
Spearman correlation between both syndromes was
r = 0.434 (p < 0.001).
Categorisation of both subscales yielded the fre-
quencies listed in Table 2. Most subjects reported low
(33.2%) or moderate (30.2%) distress in ‘schizotypal
signs’. A state of ‘no distress’ was rather uncommon
(13.2%) and extreme distress was very rare (3.7%). In
contrast, distress in ‘schizophrenia nuclear symptoms’
showed an exponential decline. The vast majority
reported no distress (70.6%), followed by low (13.5%)
and moderate (11.6%) distress. Only 0.5% reported
extreme distress.
The contingency table for distress categories is
shown in Table 3. As expected, values were statistically
highly significant (Pearson χ2 = 2652.96, df = 16,
p < 0.001). Interestingly, none of the subjects with
extreme distress in ‘schizophrenia nuclear symptoms’
reported no, low, or moderate ‘schizotypal signs’ dis-
tress. By comparison, 877 subjects with no ‘schizo-
phrenia nuclear symptoms’ distress also reported
high ‘schizotypal signs’ distress (representing 45.5%
of all subjects in that ‘schizotypal signs’ category)
while 87 reported even extreme ‘schizotypal signs’ dis-
tress (24.3%).
Table 4 presents the various factors related to ‘schi-
zotypal signs’ and ‘schizophrenia nuclear symptoms’.
Except for sex, all variables included in this analysis
had a statistically significant association with ‘schizo-
typal signs’. However, inspection of the effect sizes
for standardised mean differences revealed that most
associations were rather weak. A mean ‘schizotypal
signs’ difference of 0.11 represented a small effect;
0.29, medium; and 0.45, large. Accordingly, most
differences were small or small-to-medium. The largest
effects with respect to ‘schizotypal signs’ were found
for the mean differences between no alcohol use and
daily use (mean difference = 0.21) as well as between
married and separated/divorced/widowed (mean
difference = 0.23). In a multivariate analyses where all
predictors were entered simultaneously daily alcohol
use, daily smoking and low education remained the
strongest independent predictors. As for ‘schizo-
phrenia nuclear symptoms’, abusive drinking and
having children yielded no statistically significant
association. Sex was statistically significant, but the
Fig. 1. Distribution of ‘schizotypal signs’ (left) and ‘schizophrenia nuclear symptoms’ (right).
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effect size was marginally small and not of practical
significance. Small, medium and large effects corre-
sponding to ‘schizophrenia nuclear symptoms’ had
mean differences of 0.06, 0.16 and 0.26, respectively.
Thus, most statistically significant effects found for
‘schizophrenia nuclear symptoms’ represented mar-
ginally small effects (<0.06). The largest effects were
found for the mean ‘schizophrenia nuclear symptoms’
difference between drinking daily v. several times per
week (mean difference = 0.10) as well as between low
and high education levels (mean difference = 0.10).
When adjusted for each other, the strongest multi-
variate predictors were clearly low education and
daily alcohol use. Psychopathological syndromes
were all statistically significantly related to both sub-
scales. For ‘schizotypal signs’ the effects ranged from
medium (β > 0.3) to large (β > 0.5) size and they were
substantially larger than the moderate effects found
in ‘schizophrenia nuclear symptoms’. In each case,
the strongest psychopathological association of both
subscales was the socio-phobic syndrome (β = 0.70
and 0.40 for ‘schizotypal signs’ and ‘schizophrenia
nuclear symptoms’, respectively).
Table 5 lists the subjective appraisal of participants’
mental health. Distress in both subscales increased
exponentially with higher dissatisfaction. Subjects who
showed markedly increased distress in ‘schizotypal
signs’ and ‘schizophrenia nuclear symptoms’ were
very dissatisfied with their mental health and appraised
it as being much worse compared with that of other
persons. Each category differed significantly from all
others. The corresponding effect sizes were large.
Discussion
This study was conducted within a population
deemed to be at higher risk for mental disorders, i.e.
persons between the ages of 20 and 41. Our sample
group was obtained from a pool of almost 10 000 per-
sons representative of the general population in the
canton of Zurich, Switzerland. Although a consider-
able part of the general population had indicated
some kind of psychosis symptoms, only a small
proportion of that was connected with severe
symptoms.
The two syndromes were only moderately correlated,
i.e. establishing sufficiently distinct symptom clusters.
In particular, we noted that ‘schizotypal signs’ was
more connected to distress than was attenuated forms
of ‘schizophrenia nuclear symptoms’, even though
their distribution types were similar. The only differ-
ence was that the distribution of ‘schizophrenia nuclear
symptoms’ was more heavily peaked (demonstrating a
Table 2. Frequency of categories for ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’
Schizotypal signs Schizophrenia nuclear symptoms
N % N %
No distress 1293 13.2 6895 70.6
Low distress 3266 33.2 1315 13.5
Moderate distress 2966 30.2 1136 11.6
High distress 1938 19.7 380 3.9
Extreme distress 364 3.7 44 0.5
Total 9827 100.0 9770 100.0
Table 3. Contingency table of categories for distress within ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’
Schizophrenia nuclear symptoms distress
No (%) Low (%) Moderate (%) High (%) Extreme (%)
Schizotypal signs distress No 95.9 2.7 1.2 0.2 0.0
Low 83.7 10.8 5.1 0.4 0.0
Moderate 67.1 17.6 12.9 2.4 0.0
High 45.5 18.9 24.9 9.8 0.9
Extreme 24.3 12.8 26.3 29.1 7.5
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higher kurtosis), meaning that more subjects were situ-
ated at the lower extreme of the distribution when com-
pared with ‘schizotypal signs’. The typically inverse
Gaussian, or Wald, distribution was to be expected for
a continuously distributed symptom within the general
population. We act on the assumption of a Wald distri-
bution, i.e. continuously declining values from no/low
symptom load over moderate symptom load to high/
extreme symptom load. We don’t find in our distri-
bution a ‘zone of rarity’, characterised by very low
values between no/low and high/extreme values,
which would clearly constitute two distinct groups.
In epidemiological terms, the distribution type can
give us some hints of underlying causes of the pre-
sumed continuum. Assumed that psychosis is a multi-
factorial disorder comparable to other chronic
disorders such as diabetes, the observed distribution
of the characteristic under investigation depends on
the degree to which these causes interact, their preva-
lence and the degree to which their effect sizes differ
(Johns & van Os, 2001). If the effects of the causes
were moderate and contributed additively, we could
expect a Gaussian distribution. If the causes contribu-
ted both independently and in interaction, we expect
an inverse Gaussian distribution. We found the latter
distribution type in our study.
While we found a rather broad distribution of dis-
tress in persons with ‘schizotypal signs’, an exponen-
tial decline was noted in ‘schizophrenia nuclear
symptoms’. That is, most persons indicating the latter
displayed no distress. This possibly meant that their
‘schizophrenia nuclear symptoms’ were rather rare
events whereas ‘schizotypal signs’ were much more
pervasive and, as such, more distressing.
Table 4. Associations of ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’, adjusted for sex and age. Values followed by a different
superscript within a column vary significantly at corrected p < 0.05
Schizotypal signs Schizophrenia nuclear symptoms
Mean (95% CI) Sig.* Mean (95% CI) Sig.*
Alcohol use No 1.65a (1.62; 1.68) 0.000 1.18a (1.17; 1.20) 0.000
>1 per month 1.61b (1.59; 1.63) 1.15b (1.14; 1.17)
>1 per week 1.61b (1.59; 1.62) 1.15b (1.14; 1.16)
Daily 1.86c (1.77; 1.95) 1.25c (1.20; 1.30)
Abusive drinking No 1.59a (1.57; 1.60) 0.000 1.15a (1.13; 1.16) 0.100
Yes 1.64b (1.62; 1.65) 1.16a (1.15; 1.17)
Smoking No 1.57a (1.56; 1.58) 0.000 1.14a (1.13; 1.15) 0.000
Occasionally 1.67b (1.63; 1.71) 1.17b (1.15; 1.20)
Daily 1.76c (1.74; 1.79) 1.21c (1.20; 1.23)
Having children No 1.66a (1.64; 1.67) 0.000 1.16a (1.15; 1.17) 0.058
Yes 1.54b (1.51; 1.56) 1.15a (1.13; 1.16)
Civil state Unmarried 1.66a (1.65; 1.68) 0.000 1.16a (1.15; 1.17) 0.014
Married 1.53b (1.51; 1.55) 1.14a (1.13; 1.16)
Sep/div/widowed 1.76c (1.67; 1.85) 1.21a (1.15; 1.27)
Housing Alone 1.77a (1.73; 1.80) 0.000 1.19a (1.16; 1.21) 0.005
Community 1.60b (1.59; 1.61) 1.15b (1.15; 1.16)
Education Low 1.67a (1.65; 1.69) 0.000 1.20a (1.19; 1.21) 0.000
Moderate 1.60b (1.58; 1.62) 1.14b (1.13; 1.15)
High 1.55c (1.52; 1.57) 1.10c (1.09; 1.12)
Sex** Males 1.62a (1.60; 1.63) 0.307 1.15a (1.14; 1.16) 0.012
Females 1.61a (1.61; 1.64) 1.17b (1.16; 1.18)
β (S.E.) Sig.* β (S.E.) Sig.*
Age*** 1 S.D. increase –0.062 (0.010) 0.000 –0.052 (0.010) 0.000
Depressive 1 S.D. increase 0.619 (0.011) 0.000 0.375 (0.017) 0.000
Dysthymic 1 S.D. increase 0.534 (0.011) 0.000 0.344 (0.016) 0.000
Vegetative 1 S.D. increase 0.490 (0.012) 0.000 0.351 (0.019) 0.000
Agoraphobic 1 S.D. increase 0.489 (0.014) 0.000 0.385 (0.022) 0.000
Socio-phobic 1 S.D. increase 0.698 (0.010) 0.000 0.404 (0.017) 0.000
*Test of model effect.
**Adjusted only for age.
***Adjusted only for sex.
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The contingency table showed that subjects scoring
high on ‘schizophrenia nuclear symptoms’ scored
similarly high on ‘schizotypal signs’, whereas subjects
scoring high on the latter scored rather low or
moderate on the former. Again, persons who suffered
primarily from ‘schizotypal signs’ might have only
occasionally displayed ‘schizophrenia nuclear symp-
toms’, whereas those with distressing ‘schizophrenia
nuclear symptoms’ in the foreground were affected
pervasively in ‘schizotypal signs’.
The two syndromes were related to various covari-
ates, although mostly rather weak. The associations
with alcohol and tobacco use are replications of
well-established findings (Degenhardt & Hall, 2001;
Compton et al. 2009; Rössler et al. 2012a). One associ-
ation with the psychopathological feature of social
phobia is somewhat tautological because, by defi-
nition, ‘schizotypal signs’ are especially linked with
distrust in social relationships. Nevertheless, a sys-
tematic review also provides some evidence that social
and interpersonal dysfunctions may predate the onset
of psychotic symptoms (Gayer-Anderson & Morgan,
2013). Interestingly we found no important sex differ-
ences even though they have long been reported in
full-blown psychosis (McGrath et al. 2008). Thus,
those differences in psychosis apparently manifest
themselves at the high end of the continuum (full-
blown schizophrenia) rather than within the subthres-
hold range. Here, we confirmed results from a
previous analysis of the Zurich cohort study, in
which we also could not identify substantial sex differ-
ences in subclinical psychosis (Rössler et al. 2012b).
This finding is also in line with that from the large
meta-analysis of Linscott & van Os (2013).
By focusing on subthreshold syndromes, we have
provided evidence for subclinical psychosis syndromes
that are quite common in the general population. This
has enabled us to avoid restricting the validity of these
results only to specific high-risk groups, as currently
investigated in early psychosis-detection programmes.
Such population-based studies will allow researchers
to investigate the occurrence of psychotic symptoms
before psychopathology becomes clinically relevant.
Nevertheless, we could previously demonstrate that a
high symptom load of the two syndromes assessed, is
associated with various kinds of functional impairments
(Rössler et al. 2007). Furthermore, those symptomswill be
meaningful for prevention and intervention pro-
grammes, because we have already demonstrated that
they may predispose a person to a wide range of mental
disorders (Rössler et al. 2011a). Finally, subclinical psy-
chosis detrimentally impacts the course and severity of
affective disorders (Wigman et al. 2012), and it constitutes
a risk factor for suicidal behaviour (Kelleher et al. 2012).
Accordingly, we have determined in our study that the
two syndromes are not meaningless for the lives of
affected persons. In particular, ‘schizotypal signs’ impair
the subjective well-being and satisfaction with mental
health when compared with others. This is much less
the case with respect to ‘schizophrenia nuclear symp-
toms’, probably because those symptoms are not as fre-
quent and pervasive.
In summary, our description of these two sufficiently
discrete syndromes can reduce the heterogeneityof symp-
toms associated with subclinical psychosis. In this study
we verified the usefulness of those syndromes as pre-
viously assessed in other representative samples (Rössler
et al. 2007, 2011b; Breetvelt et al. 2010). Both syndromes
Table 5. Subjective appraisal of mental health in association with ‘schizotypal signs’ and ‘schizophrenia nuclear symptoms’, adjusted for sex




Mean (S.E.) Sig.* Mean (S.E.) Sig.*
Individual satisfaction with mental health Very low 2.71a (0.09) 0.000 1.69a (0.09) 0.000
Low 2.34b (0.04) 1.37b (0.03)
Moderate 1.99c (0.02) 1.27c (0.01)
High 1.63d (0.01) 1.16d (0.01)
Very high 1.40e (0.01) 1.09e (0.00)
Comparison of mental health with others Much worse 2.59a (0.09) 0.000 1.55a (0.09) 0.000
Worse 2.12b (0.03) 1.29b (0.02)
Equal 1.67c (0.01) 1.17c (0.01)
Better 1.55d (0.01) 1.14d (0.00)
Much better 1.46e (0.01) 1.11e (0.01)
*Test of model effect.
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feature similar syndromes that are used to characterise
full-blown psychosis. Therefore, they are particularly
appropriate for describing the psychosis continuum.
However, the present study did involve some limit-
ations. The telephone interviews were conducted by
laypersons, and the assessed variables were quite
restricted in number and detail. Nevertheless, we
were able to canvass a large representative sample
when compared with most other investigations that
have focused on subclinical psychosis within a general
population. Information about service use was not
available for this large screening sample. Therefore,
we do not know how professional treatment may
eventually have affected our results.
In addition to the more specific limitations of our
study, there are some more general concerns about
assessment approaches in psychiatric epidemiology.
Firstly, the content of the described phenomena can
never go beyond the actually assessed symptoms or
signs. That is to say that we cannot definitely decide
if the two syndromes identified are natural entities or
resulting from the structure of our questionnaires. As
such the applied questionnaires determine the content
and the distribution type of the epidemiological find-
ings. Additionally, the fewer items assessed the more
rough the estimates will be.
Concerning our research question we find two types
of items, the ones representing the same symptoms as
seen in manifest psychosis, i.e. schizophrenia nuclear
symptoms but less pronounced in intensity and quan-
tity and attenuated psychosis symptoms, i.e. weaker as
described in ‘schizotypal signs’ compared with full-
blown symptoms. The former type of symptoms
suggests that this type of symptom only turns into a dis-
order, e.g. depending on the degree of subjective dis-
tress or in a certain cultural context implying various
levels of societal tolerance. The latter type of symptoms
(schizotypal signs) is an attenuated form with varying
degrees of severity along a continuum, i.e. precursors
of a psychotic disorder. The continuity of symptoms is
implied as on inspection the values of our scale are con-
tinuously decreasing from ‘no/low’ to ‘high/extreme’.
But we cannot hypothesise a continuum from normal
experiences to clinical phenomena, as we did not assess
manifest psychosis in our sample.
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